Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $103,000.00 in Stock

Key Points

• Major shareholder Jennifer Pritzker sold 4,000 OrthoPediatrics shares at an average price of $25.75, generating $103,000. She continues to own 6.9 million shares worth approximately $177.6 million.
• OrthoPediatrics shares fell 1.9% to $24.03, while the company reported quarterly revenue of $70.51 million and an adjusted loss of $0.26 per share—both better than analyst expectations.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $26.44; institutional investors own approximately 69.05% of the stock.

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) major shareholder Jennifer Pritzker sold 4,000 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $25.75, for a total value of $103,000.00. Following the completion of the sale, the insider owned 6,897,764 shares of the company's stock, valued at approximately $177,617,423. This trade represents a 0.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Down 1.9%

Shares of KIDS stock traded down $0.47 during trading hours on Wednesday, reaching $24.03. 169,608 shares of the company's stock were exchanged, compared to its average volume of 171,545. OrthoPediatrics Corp. has a 1 year low of $14.42 and a 1 year high of $26.74. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. The stock has a market cap of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. The stock's fifty day moving average price is $21.11 and its two-hundred day moving average price is $18.53.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.04. The firm had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. Research analysts predict that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. TD Cowen reissued a "buy" rating on shares of OrthoPediatrics in a report on Monday, June 15th. BTIG Research raised their target price on OrthoPediatrics from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Thursday, August 20th. Needham & Company LLC lifted their price target on OrthoPediatrics from $30.00 to $35.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Truist Financial set a $22.00 price target on OrthoPediatrics in a research note on Wednesday, August 5th. Finally, Weiss Ratings raised OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $26.44.

Institutional Trading of OrthoPediatrics

Large investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in OrthoPediatrics by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after purchasing an additional 645 shares during the period. Millennium Management LLC grew its position in OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company's stock worth $16,172,000 after purchasing an additional 233,873 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of OrthoPediatrics by 112.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company's stock valued at $4,937,000 after buying an additional 106,041 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of OrthoPediatrics during the 1st quarter valued at about $389,000. Finally, American Century Companies Inc. lifted its holdings in shares of OrthoPediatrics by 12.5% in the 2nd quarter. American Century Companies Inc. now owns 34,486 shares of the company's stock valued at $741,000 after buying an additional 3,828 shares during the period. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source